Affimed NV (AFMD)
2.67
-0.05
(-1.84%)
USD |
NASDAQ |
Nov 21, 14:31
Affimed Market Cap: 43.77M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 44.59M |
| November 19, 2024 | 49.18M |
| November 18, 2024 | 51.80M |
| November 15, 2024 | 57.05M |
| November 14, 2024 | 59.83M |
| November 13, 2024 | 61.47M |
| November 12, 2024 | 61.64M |
| November 11, 2024 | 62.62M |
| November 08, 2024 | 63.11M |
| November 07, 2024 | 62.78M |
| November 06, 2024 | 58.52M |
| November 05, 2024 | 60.00M |
| November 04, 2024 | 53.60M |
| November 01, 2024 | 53.44M |
| October 31, 2024 | 52.95M |
| October 30, 2024 | 54.75M |
| October 29, 2024 | 54.91M |
| October 28, 2024 | 55.24M |
| October 25, 2024 | 54.50M |
| October 24, 2024 | 54.42M |
| October 23, 2024 | 55.57M |
| October 22, 2024 | 57.05M |
| October 21, 2024 | 55.73M |
| October 18, 2024 | 58.19M |
| October 17, 2024 | 54.26M |
| Date | Value |
|---|---|
| October 16, 2024 | 54.59M |
| October 15, 2024 | 51.23M |
| October 14, 2024 | 51.14M |
| October 11, 2024 | 49.18M |
| October 10, 2024 | 49.01M |
| October 09, 2024 | 50.82M |
| October 08, 2024 | 51.47M |
| October 07, 2024 | 51.80M |
| October 04, 2024 | 52.62M |
| October 03, 2024 | 53.44M |
| October 02, 2024 | 53.93M |
| October 01, 2024 | 54.26M |
| September 30, 2024 | 55.08M |
| September 27, 2024 | 52.69M |
| September 26, 2024 | 51.75M |
| September 25, 2024 | 51.90M |
| September 24, 2024 | 53.16M |
| September 23, 2024 | 53.31M |
| September 20, 2024 | 57.86M |
| September 19, 2024 | 62.10M |
| September 18, 2024 | 63.04M |
| September 17, 2024 | 63.82M |
| September 16, 2024 | 62.41M |
| September 13, 2024 | 62.72M |
| September 12, 2024 | 60.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
43.77M
Minimum
Nov 21 2024
1.356B
Maximum
Apr 28 2021
348.54M
Average
237.90M
Median
May 28 2020
Market Cap Benchmarks
| InflaRx NV | 122.48M |
| BioNTech SE | 25.71B |
| Immatics NV | 928.64M |
| CureVac NV | 569.82M |
| ATAI Life Sciences NV | 255.06M |
Market Cap Related Metrics
| PS Ratio | 43.23 |
| Price to Book Value | 2.279 |
| Price | 2.67 |
| Earnings Yield | -185.6% |